Senior Director, Scientific Fellow
Janssen Research & Development
Weirong Wang, PhD, is a Senior Director in the Clinical Pharmacology and Pharmacometrics Department at Johnson & Johnson. Her team is responsible for using QSP and mechanism-based PK/PD modeling to support JNJ’s clinical portfolio across multiple therapeutic areas. Dr. Wang has over 20 years of experience in the discovery and development of biotherapeutics. She received her B.S. in Biochemistry from Fudan University in China and her Ph.D. in Molecular Biology and Biochemistry from Rutgers, the State University of New Jersey. Dr. Wang joined JNJ in 2011 and has led multiple groups focusing on the development and application of mechanism- and physiologically-based models. Prior to joining JNJ, Weirong worked at Merck & Co. and a biotech company called CuraGen. She has authored or co-authored more than 50 peer-reviewed papers, reviews and book chapters.